市場調査レポート

商品コード

1593502

酒さ治療の市場規模・シェア・成長分析 (種類別、薬剤クラス別、送達経路別、地域別)：産業予測 (2024～2031年)

Rosacea Treatment Market Size, Share, Growth Analysis, By Type (Erythematotelangiectatic Rosacea, Papulopustular Rosacea), By Drug Class(Antibiotics, Alpha), By Mode of Administration (Topical, Oral), By Region - Industry Forecast 2024-2031

出版日: 2024年11月09日
発行: SkyQuest
ページ情報: 英文 194 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の酒さ治療の市場規模は2023年に17億9,000万米ドルで、予測期間 (2024～2031年) のCAGRは6.5%で、2024年の19億1,000万米ドルから2031年には31億6,000万米ドルに増加すると予測されています。

皮膚疾患の急増とスキンケアに対する世界の意識の高まりが、酒さ治療市場を前進させています。特に、寒冷地や色白の肌の人は酒さにかかりやすく、北米や欧州での需要を牽引しています。さらに、美容皮膚科学への注目の高まりと革新的な治療法の出現が、酒さ治療を専門とする企業に新たな成長の道をもたらしています。治療手法の技術的進歩は、これらの業者にとって長期的な収益の可能性をさらに高めています。しかし、現在酒さには決定的な治療法がなく、利用可能な治療法についての認識不足や潜在的な副作用に関する懸念につながっているため、課題も残っています。これらの要因は、世界規模での酒さ治療の全体的な見通しを妨げる可能性があり、これらの障壁を軽減し、このニッチ分野の市場成長をさらに刺激するために、積極的な教育とコミュニケーション戦略が必要です。

北米 (種類別、治療薬の種類別、薬剤クラス別、流通チャネル別)
- 米国
- カナダ
欧州 (種類別、治療薬の種類別、薬剤クラス別、流通チャネル別)
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州
アジア太平洋 (種類別、治療薬の種類別、薬剤クラス別、流通チャネル別)
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ (種類別、治療薬の種類別、薬剤クラス別、流通チャネル別)
- ブラジル
- その他ラテンアメリカ
中東・アフリカ (種類別、治療薬の種類別、薬剤クラス別、流通チャネル別)
- 湾岸協力会議 (GCC) 諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング (2023年)
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析 (2023年)
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の対前年成長率 (YoY) の比較 (2021～2023年)

主要企業プロファイル

Gary Pharmaceuticals P Limited
Hovione
Pfizer Inc.
PruGen Pharmaceuticals
Glenmark Pharmaceuticals
Cipla Ltd.
Lupin
VYNE Therapeutics
Bayer AG
Bausch Health Companies Inc.
AbbVie Inc.
Eckson Labs
Sandoz Spa
Galderma
Abigail Care Pharmaceutical
Aclaris Therapeutics
Colorescience, Inc
Croda International Plc
Dr. Reddy's Laboratories Ltd
Leopharma

結論と推奨事項

Product Code: SQMIG30L2257

Global Rosacea Treatment Market was valued at USD 1.79 Billion in 2023 and is expected to rise from USD 1.91 Billion in 2024 to USD 3.16 Billion by 2031, at a CAGR of 6.5% during the forecast period (2024-2031).

The surge in skin disorders, paired with heightened global awareness of skincare, is propelling the rosacea treatment market forward. Notably, individuals in colder climates and those with fair skin are particularly vulnerable to rosacea, driving demand especially in North America and Europe. Additionally, the increasing focus on aesthetic dermatology, coupled with the emergence of innovative treatment options, presents new growth avenues for companies specializing in rosacea care. Technological advancements in treatment methodologies further enhance the revenue potential for these providers over the long term. However, challenges remain, as there is currently no definitive cure for rosacea, leading to a lack of awareness about available treatments and concerns regarding potential side effects. These factors may hinder the overall outlook for rosacea treatments on a global scale, necessitating proactive education and communication strategies to mitigate these barriers and further stimulate market growth in this niche sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rosacea Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rosacea Treatment Market Segmental Analysis

Global Rosacea Treatment Market is segmented by Type, Treatment Type, Drug Class, Distribution Channel and region. Based on Type, the market is segmented into Erythematotelangiectatic rosacea, Papulopustular rosacea, Ocular rosacea, Phymatous rosacea. Based on Treatment Type, the market is segmented into Oral, Topical, Other treatment types. Based on Drug Class, the market is segmented into Antibiotic, Alpha agonist, Retinoid, Corticosteroid, Immunosuppressant, Other drug classes. Based on Distribution Channel, the market is segmented into Hospital pharmacies,Retail pharmacies, Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Rosacea Treatment Market

The growing incidence of rosacea globally serves as a significant market driver for the Global Rosacea Treatment market. Heightened awareness about the condition's symptoms has led to more individuals seeking diagnosis and treatment, resulting in an increased patient population. Additionally, the surging number of individuals residing in colder climates, where rosacea is more prevalent, further amplifies the demand for effective treatment options. This combination of rising awareness and environmental factors is stimulating growth in the market, prompting innovative therapies, advanced dermatological solutions, and increased investment from pharmaceutical companies aiming to address the escalating needs of affected patients worldwide.

Restraints in the Global Rosacea Treatment Market

The absence of a definitive cure for rosacea serves as a significant market restraint for the global rosacea treatment sector, as existing therapies primarily focus on managing symptoms rather than providing a permanent solution. This limitation not only constrains patient satisfaction and long-term adherence to treatment plans but also curtails market growth potential, as healthcare providers and patients alike seek more effective and lasting options. Furthermore, the reliance on symptom management generates a cycle of ongoing treatment and costs, reducing the overall market appeal and hindering investment in research and development for innovative, curative therapies.

Market Trends of the Global Rosacea Treatment Market

The Global Rosacea Treatment market is experiencing a significant trend towards the incorporation of natural and organic ingredients in treatment products. As consumer awareness grows regarding the benefits of harnessing natural solutions for skin conditions, companies are increasingly pivoting their formulations to meet these demands. This shift not only aligns with the overarching trend of clean beauty but also positions brands to differentiate themselves in a competitive landscape. By focusing on safe, effective, and environmentally-friendly options, rosacea treatment providers are poised to capture a broader market share, thereby creating new business opportunities and fostering customer loyalty in the long term.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
Customer & Buying Criteria Analysis
PESTEL Analysis
Macro-Economic Indicators

Global Rosacea Treatment Market Size by Type & CAGR (2024-2031)

Erythematotelangiectatic Rosacea
Papulopustular Rosacea
Ocular Rosacea
Phymatous Rosacea

Global Rosacea Treatment Market Size by Treatment Type & CAGR (2024-2031)

Oral
Topical
Other Treatment Types

Global Rosacea Treatment Market Size byDrug Class & CAGR (2024-2031)

Antibiotic
Alpha agonist
Retinoid
Corticosteroid
Immunosuppressant
Other drug classes

Global Rosacea Treatment Market Size byDistribution Channel & CAGR (2024-2031)

Hospital pharmacies
Retail pharmacies
Online pharmacies

Global Rosacea Treatment Market Size & CAGR (2024-2031)

North America, (Type, Treatment Type, Drug Classes, Distribution Channels)
- US
- Canada
Europe, (Type, Treatment Type, Drug Classes, Distribution Channels)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Type, Treatment Type, Drug Classes, Distribution Channels)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Type, Treatment Type, Drug Classes, Distribution Channels)
- Brazil
- Rest of Latin America
Middle East & Africa, (Type, Treatment Type, Drug Classes, Distribution Channels)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Gary Pharmaceuticals P Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hovione
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PruGen Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glenmark Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lupin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VYNE Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch Health Companies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eckson Labs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sandoz Spa
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galderma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abigail Care Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aclaris Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Colorescience, Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Croda International Plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leopharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

酒さ治療の市場規模・シェア・成長分析 (種類別、薬剤クラス別、送達経路別、地域別)：産業予測 (2024～2031年)

Rosacea Treatment Market Size, Share, Growth Analysis, By Type (Erythematotelangiectatic Rosacea, Papulopustular Rosacea), By Drug Class(Antibiotics, Alpha), By Mode of Administration (Topical, Oral), By Region - Industry Forecast 2024-2031

目次

イントロダクション

分析手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

世界の酒さ治療の市場規模 (種類別)・CAGR (2024～2031年)

世界の酒さ治療の市場規模 (治療薬の種類別)・CAGR (2024～2031年)

世界の酒さ治療の市場規模 (薬剤クラス別)・CAGR (2024～2031年)

世界の酒さ治療の市場規模 (流通チャネル別)・CAGR (2024～2031年)

世界の酒さ治療の市場規模・CAGR (2024～2031年)